319 related articles for article (PubMed ID: 33120986)
1. Evaluation of Polyhedral Oligomeric Silsesquioxane Porphyrin Derivatives on Photodynamic Therapy.
Siano P; Johnston A; Loman-Cortes P; Zhin Z; Vivero-Escoto JL
Molecules; 2020 Oct; 25(21):. PubMed ID: 33120986
[TBL] [Abstract][Full Text] [Related]
2. Enhancing the Efficacy of Photodynamic Therapy through a Porphyrin/POSS Alternating Copolymer.
Jin J; Zhu Y; Zhang Z; Zhang W
Angew Chem Int Ed Engl; 2018 Dec; 57(50):16354-16358. PubMed ID: 30318668
[TBL] [Abstract][Full Text] [Related]
3. Peptide 18-4/chlorin e6-conjugated polyhedral oligomeric silsesquioxane nanoparticles for targeted photodynamic therapy of breast cancer.
Kim YJ; Lee HI; Kim JK; Kim CH; Kim YJ
Colloids Surf B Biointerfaces; 2020 May; 189():110829. PubMed ID: 32036332
[TBL] [Abstract][Full Text] [Related]
4. Photosensitizer (PS)/polyhedral oligomeric silsesquioxane (POSS)-crosslinked nanohybrids for enhanced imaging-guided photodynamic cancer therapy.
Zhu YX; Jia HR; Chen Z; Wu FG
Nanoscale; 2017 Sep; 9(35):12874-12884. PubMed ID: 28686273
[TBL] [Abstract][Full Text] [Related]
5. Use of Polyhedral Oligomeric Silsesquioxane (POSS) in Drug Delivery, Photodynamic Therapy and Bioimaging.
Loman-Cortes P; Binte Huq T; Vivero-Escoto JL
Molecules; 2021 Oct; 26(21):. PubMed ID: 34770861
[TBL] [Abstract][Full Text] [Related]
6. Nanoscale Organic-Inorganic Hybrid Photosensitizers for Highly Effective Photodynamic Cancer Therapy.
Chen J; Xu Y; Gao Y; Yang D; Wang F; Zhang L; Bao B; Wang L
ACS Appl Mater Interfaces; 2018 Jan; 10(1):248-255. PubMed ID: 29241325
[TBL] [Abstract][Full Text] [Related]
7. Design and Synthesis of New Porphyrin Analogues as Potent Photosensitizers for Photodynamic Therapy: Spectroscopic Approach.
Mahajan PG; Dige NC; Vanjare BD; Kim CH; Seo SY; Lee KH
J Fluoresc; 2020 Mar; 30(2):397-406. PubMed ID: 32088851
[TBL] [Abstract][Full Text] [Related]
8. Effect of axial ligands on the molecular configurations, stability, reactivity, and photodynamic activities of silicon phthalocyanines.
Luan L; Ding L; Shi J; Fang W; Ni Y; Liu W
Chem Asian J; 2014 Dec; 9(12):3491-7. PubMed ID: 25303635
[TBL] [Abstract][Full Text] [Related]
9. Polyhedral Oligomeric Silsesquioxane (POSS)-Based Cationic Conjugated Oligoelectrolyte/Porphyrin for Efficient Energy Transfer and Multiamplified Antimicrobial Activity.
Chen J; Shan J; Xu Y; Su P; Tong L; Yuwen L; Weng L; Bao B; Wang L
ACS Appl Mater Interfaces; 2018 Oct; 10(40):34455-34463. PubMed ID: 30211531
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, Photophysical Properties and Application of New Porphyrin Derivatives for Use in Photodynamic Therapy and Cell Imaging.
Mahajan PG; Dige NC; Vanjare BD; Phull AR; Kim SJ; Hong SK; Lee KH
J Fluoresc; 2018 Jul; 28(4):871-882. PubMed ID: 30014275
[TBL] [Abstract][Full Text] [Related]
11. Iron oxide nanoparticles functionalized with novel hydrophobic and hydrophilic porphyrins as potential agents for photodynamic therapy.
Penon O; Marín MJ; Amabilino DB; Russell DA; Pérez-García L
J Colloid Interface Sci; 2016 Jan; 462():154-65. PubMed ID: 26454374
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and in vitro PDT evaluation of new porphyrins containing meso-epoxymethylaryl cationic groups.
Carneiro J; Gonçalves A; Zhou Z; Griffin KE; Kaufman NEM; Vicente MDGH
Lasers Surg Med; 2018 Jul; 50(5):566-575. PubMed ID: 29691890
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic inactivation of Candida albicans using bridged polysilsesquioxane films doped with porphyrin.
Alvarez MG; Gómez ML; Mora SJ; Milanesio ME; Durantini EN
Bioorg Med Chem; 2012 Jul; 20(13):4032-9. PubMed ID: 22672980
[TBL] [Abstract][Full Text] [Related]
14. Enhanced cellular uptake of protoporphyrine IX/linolenic acid-conjugated spherical nanohybrids for photodynamic therapy.
Lee HI; Kim YJ
Colloids Surf B Biointerfaces; 2016 Jun; 142():182-191. PubMed ID: 26954084
[TBL] [Abstract][Full Text] [Related]
15. New porphyrin photosensitizers-Synthesis, singlet oxygen yield, photophysical properties and application in PDT.
Wang X; Lv H; Sun Y; Zu G; Zhang X; Song Y; Zhao F; Wang J
Spectrochim Acta A Mol Biomol Spectrosc; 2022 Oct; 279():121447. PubMed ID: 35689847
[TBL] [Abstract][Full Text] [Related]
16. Properties of halogenated and sulfonated porphyrins relevant for the selection of photosensitizers in anticancer and antimicrobial therapies.
Pucelik B; Paczyński R; Dubin G; Pereira MM; Arnaut LG; Dąbrowski JM
PLoS One; 2017; 12(10):e0185984. PubMed ID: 29016698
[TBL] [Abstract][Full Text] [Related]
17. Studies on the Synthesis, Photophysical and Biological Evaluation of Some Unsymmetrical Meso-Tetrasubstituted Phenyl Porphyrins.
Boscencu R; Manda G; Radulea N; Socoteanu RP; Ceafalan LC; Neagoe IV; Ferreira Machado I; Basaga SH; Vieira Ferreira LF
Molecules; 2017 Oct; 22(11):. PubMed ID: 29068406
[No Abstract] [Full Text] [Related]
18. Palladium porphyrin complexes for photodynamic cancer therapy: effect of porphyrin units and metal.
Deng J; Li H; Yang M; Wu F
Photochem Photobiol Sci; 2020 Jul; 19(7):905-912. PubMed ID: 32369050
[TBL] [Abstract][Full Text] [Related]
19. Enhanced photodynamic efficacy towards melanoma cells by encapsulation of Pc4 in silica nanoparticles.
Zhao B; Yin JJ; Bilski PJ; Chignell CF; Roberts JE; He YY
Toxicol Appl Pharmacol; 2009 Dec; 241(2):163-72. PubMed ID: 19695274
[TBL] [Abstract][Full Text] [Related]
20. Meso-tetrakis(p-sulfonatophenyl)N-confused porphyrin tetrasodium salt: a potential sensitizer for photodynamic therapy.
Thomas AP; Saneesh Babu PS; Asha Nair S; Ramakrishnan S; Ramaiah D; Chandrashekar TK; Srinivasan A; Radhakrishna Pillai M
J Med Chem; 2012 Jun; 55(11):5110-20. PubMed ID: 22582931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
